https://clinicaltrials.gov/ct2/show/NCT03636347?type=Intr&cond=COPD&phase=01234&lupd_s=11%2F01%2F2018&lupd_d=14&sort=nwst A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. Conditions : Alpha 1-Antitrypsin Deficiency; Emphysema; COPD Interventions : Drug: Placebo Oral Tablet; Drug: Alvelestat oral tablet – dose 1; Drug: Alvelestat oral tablet – dose 2 Sponsors : Mereo BioPharma; Syneos Health Recruiting NCT03636347 Fri, 17 Aug 2018 12:00:00 EDT
